Anticoagulants – Uses, Effects and Side Effects
Anticoagulants are medications that inhibit blood clotting and help prevent dangerous blood clots. They are used in conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation.
Things worth knowing about "Anticoagulants"
Anticoagulants are medications that inhibit blood clotting and help prevent dangerous blood clots. They are used in conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation.
What Are Anticoagulants?
Anticoagulants are medications that slow down or inhibit the blood clotting process. They are commonly referred to as blood thinners, although they do not actually make the blood thinner or more fluid. Instead, they interfere with specific steps in the coagulation cascade to prevent the formation or growth of blood clots (thrombi).
When Are Anticoagulants Used?
Anticoagulants are prescribed to prevent the formation of blood clots or to stop existing clots from growing. Common indications include:
- Deep vein thrombosis (DVT): Blood clots in the deep veins of the legs
- Pulmonary embolism: Blockage of a pulmonary artery by a clot
- Atrial fibrillation: A heart rhythm disorder associated with an increased risk of stroke
- Mechanical heart valves: Increased clotting risk due to artificial materials
- Stroke prevention: Reducing the risk of further events after an ischemic stroke
- Post-surgical thromboprophylaxis: Prevention of clots after major surgery or prolonged immobility
Mechanism of Action
Blood clotting is a complex process involving multiple coagulation factors. Anticoagulants target different points within this cascade:
Vitamin K Antagonists (VKA)
Agents such as warfarin or phenprocoumon inhibit the synthesis of clotting factors that depend on vitamin K (factors II, VII, IX, and X). Their effect is delayed in onset and requires regular monitoring through the INR value (International Normalized Ratio).
Heparins
Unfractionated heparin (UFH) and low molecular weight heparins (LMWH) such as enoxaparin or nadroparin enhance the activity of antithrombin, a natural inhibitor of coagulation. They are typically administered by subcutaneous injection or intravenously.
Direct Oral Anticoagulants (DOACs)
The newer class of direct oral anticoagulants (also called NOACs) selectively inhibit individual clotting factors:
- Factor Xa inhibitors: Rivaroxaban, apixaban, edoxaban
- Thrombin inhibitors (Factor IIa inhibitors): Dabigatran
These medications offer the advantage of fixed dosing and generally do not require routine coagulation monitoring.
Dosage and Administration
The dosing of anticoagulants depends on the indication, the individual risk profile of the patient, and the function of the kidneys and liver. Vitamin K antagonists require regular blood tests (INR monitoring) to guide dose adjustments. DOACs are typically taken at a fixed daily dose, although dose reduction may be necessary in patients with impaired kidney function.
Side Effects
The most significant risk associated with all anticoagulants is an increased tendency to bleed. Potential bleeding complications include:
- Gastrointestinal bleeding
- Intracranial hemorrhage (in rare cases)
- Prolonged bleeding after injuries or surgical procedures
- Easy bruising (hematomas) from minor trauma
With heparins, a rare but serious complication known as heparin-induced thrombocytopenia (HIT) can occur -- a paradoxical condition in which the risk of clotting is actually increased despite anticoagulant therapy.
Important Considerations and Interactions
Anticoagulants can interact with many other medications and foods. Key interactions include:
- Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin further increase bleeding risk.
- Vitamin K-rich foods (e.g., spinach, kale) can reduce the effectiveness of vitamin K antagonists.
- Certain antibiotics, antifungals, and other drugs may enhance or diminish anticoagulant effects.
Patients on anticoagulant therapy should always carry an anticoagulant card and inform all treating physicians and dentists about their medication.
References
- Steffel J. et al. - The 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. European Heart Journal, 2021.
- Kearon C. et al. - Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 2016.
- Pschyrembel Clinical Dictionary. 268th Edition. De Gruyter, Berlin, 2020.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalorie deficit
Macronutrients
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Anticoagulants-en